Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer
2021 StandoutNobel
Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma
2015
Hallmarks of Cancer: The Next Generation
2011 Standout
Proteomics-based Identification of Novel Factor Inhibiting Hypoxia-inducible Factor (FIH) Substrates Indicates Widespread Asparaginyl Hydroxylation of Ankyrin Repeat Domain-containing Proteins
2008 StandoutNobel
The Role of KRAS Mutation Testing in the Management of Patients With Metastatic Colorectal Cancer
2009
EGFR Antagonists in Cancer Treatment
2008 Standout
Function of alternative splicing
2004
Quantification of mRNA using real-time RT-PCR
2006 Standout
mTOR Signaling in Growth Control and Disease
2012 Standout
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Horizontal Gene Transfer from Diverse Bacteria to an Insect Genome Enables a Tripartite Nested Mealybug Symbiosis
2013 Standout
Liquid biopsy enters the clinic — implementation issues and future challenges
2021
Hallmarks of aging: An expanding universe
2023 Standout
Cellular Senescence in Cancer and Aging
2007 Standout
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Tankyrase function at telomeres, spindle poles, and beyond
2007
Plasticity of disseminating cancer cells in patients with epithelial malignancies
2012
The molecular biology of head and neck cancer
2010 Standout
Deep sequencing: Becoming a critical tool in clinical virology
2014
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Phaeochromocytoma in children
2008
Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas
2011
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Circulating tumour cells in cancer patients: challenges and perspectives
2010
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients
2010
Emerging evidence on the pathobiology of mucositis
2013
Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
2011
mTOR: from growth signal integration to cancer, diabetes and ageing
2010 Standout
SDH mutations in cancer
2011
Measurement of Eicosanoids in Cancer Tissues
2007
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Cancer micrometastases
2009
Emerging Biological Principles of Metastasis
2017 Standout
Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility
2010 StandoutNobel
EMT: 2016
2016 Standout
Eicosanoids and cancer
2010 Standout
4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors
2010
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
2012 Standout
Cytokinesis-block micronucleus cytome assay
2007 Standout
Dysregulated pH: a perfect storm for cancer progression
2011 Standout
The biogenesis, biology and characterization of circular RNAs
2019 Standout
Clinical aspects of SDHx-related pheochromocytoma and paraganglioma
2009
Reconciling the distinct roles of angiogenic/anti-angiogenic factors in the placenta and maternal circulation of normal and pathological pregnancies
2019
Telomeres and human disease: ageing, cancer and beyond
2005
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Detection, clinical relevance and specific biological properties of disseminating tumour cells
2008
High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer
2010
DnaSP 6: DNA Sequence Polymorphism Analysis of Large Data Sets
2017 Standout
Clinical applications of the CellSearch platform in cancer patients
2018
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
Technologies for detection of circulating tumor cells: facts and vision
2013
Mitochondria and cancer
2012 Standout
Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment
2015
Review: Biological relevance of disseminated tumor cells in cancer patients
2008
SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma–paraganglioma syndromes
2009
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Comprehensive qPCR profiling of gene expression in single neuronal cells
2011 StandoutNobel
Real-time reverse transcription PCR and the detection of occult disease in colorectal cancer
2006
KRAS Mutations and Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer: Practical Application of Patient Selection
2009
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta
2023 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
The Succinate Dehydrogenase Genetic Testing in a Large Prospective Series of Patients with Paragangliomas
2009
Genetic Screening for von Hippel-Lindau Gene Mutations in Non-syndromic Pheochromocytoma: Low Prevalence and False-positives or Misdiagnosis Indicate a Need for Caution
2012
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Measurements of Plasma Methoxytyramine, Normetanephrine, and Metanephrine as Discriminators of Different Hereditary Forms of Pheochromocytoma
2011
Characterization of Somatostatin Receptor Subtype 2 Expression in Stably Transfected A-427 Human Cancer Cells
2007
EQUAL-quant: An International External Quality Assessment Scheme for Real-Time PCR
2006
Circulating Tumor Cells and Bone Marrow Micrometastasis
2008
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
The role of KRAS mutation testing in the management of patients with metastatic colorectal cancer.
2009
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Works of Lisa Simi being referenced
The pre-analytical phase of the liquid biopsy
2019
High-Resolution Melting Analysis for Rapid Detection ofKRAS, BRAF,andPIK3CAGene Mutations in Colorectal Cancer
2008
An Italian program of external quality control for quantitative assays based on real-time PCR with Taq-Man™ probes
2005
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer
2011
Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer
2006
Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase–polymerase chain reaction results and feasibility of molecular analysis by laser microdissection
2006
Genetic screening for pheochromocytoma: should SDHC gene analysis be included?: Figure 1
2007
Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer
2004
Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X
2005
VEGF expression in the placenta from pregnancies complicated by hypertensive disorders
2004
Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations
2007
Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer
2008
SDH Mutations in Patients Affected by Paraganglioma Syndromes
2006
Monitoring the susceptibility to oseltamivir of Influenza A(H1N1) 2009 virus by nested-PCR and pyrosequencing during the pandemic and in the season 2010–2011
2012
Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cells
2006
Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue.
2004
The somatic affairs of BRAF : tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutations
2013
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer
2016